fines
Teva under investigation for marketing practices
February 12, 2014Sales and Marketing Azilect, Copaxone, Teva, fines, generics
Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …
Ranbaxy quality issues hit sixth plant; seeks Diovan workaround
January 20, 2014Manufacturing and Production FDA, Ranbaxy, fines, manufacturing
Yet another plant operated by India’s Ranbaxy has been held up by US Food and Drug Administration over quality deficiencies, …
€16 million fines for J&J and Novartis
December 12, 2013Medical Communications, Sales and Marketing EU, J&J, JJ, Novartis, Sandoz, fentanyl, fines
The European Commission has slapped multi-million euro fines on Johnson & Johnson and Novartis for what it says were ‘shocking’ …
J&J ‘to pay out $4 billion’ in fresh legal case
November 14, 2013Sales and Marketing J&J, JJ, Risperdal, fines, hip replacement
Johnson & Johnson is set to pay up to $4 billion to settle thousands of legal cases related to patients …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
